BeiGene

Partner Level

Diamond

BeiGene is a global, commercial-stage biotechnology company focused on discovering, developing, manufacturing, and commercializing innovative medicines to improve treatment outcomes and access for patients worldwide. Our 5,400+ employees around the world are committed to expediting the development of a diverse pipeline of novel therapeutics.

BeiGene: Blood Cancer Has No Borders, Neither Do We: https://youtu.be/UUoKZYigazk

More information:

• • Prescribing Information
  • Dosing and Administration
  • Patient Support
  • Learn More about BeiGene
  • BeiGene Corporate Brochure
  • BRUKINSA for the treatment of WM
  • BRUKINSA for the treatment of MCL
  • Brukinsa Patient Brochure
  • myBeiGene

Click the link to view BeiGene’s activities and presentations presented this year during the 25^th European Hematology Association (EHA) Virtual Congress that took place on June 11-14. http://ir.beigene.com/news-releases/news-release-details/beigene-presents-clinical-data-zanubrutinib-and-tislelizumab?loc=US